Role of radioimmunolocalization in the staging of gastric carcinoma

Seminars in Surgical Oncology

Volumn 15, Issue 4, 1998, Pages 209-211

  Mussa, Antonio ^a   Sandrucci, Sergio ^a,b   Mobiglia, Alberto ^a   Baccega, Massimo ^b   Mussa, Baudolino ^a   De Filippi, Pier Giuseppe ^b  

^a UNIVERSITY OF TURIN   (Italy)

^b Azienda Ospedaliera   (Italy)

Author keywords

Adenocarcinoma; Carcinoembryonic antigen; Immunohistochemistry; Indium radioisotopes; Lymph node excision; Lymph node metastasis; Monoclonal antibodies; Neoplasm staging; Radioimmunodetection; Sensitivity and specificity; Stomach neoplasms; Survival rate

Indexed keywords

CARCINOEMBRYONIC ANTIBODY; INDIUM 111; MONOCLONAL ANTIBODY B.72.3; ONCOSCINT; UNCLASSIFIED DRUG;

AGED; CANCER INVASION; CANCER LOCALIZATION; CANCER STAGING; CASE REPORT; CONFERENCE PAPER; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; INTRAVENOUS DRUG ADMINISTRATION; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MINIMAL RESIDUAL DISEASE; PARTIAL GASTRECTOMY; PEROPERATIVE CARE; PRIORITY JOURNAL; RADIOIMMUNOLOGY; RADIOSURGERY; STOMACH CARCINOMA;

EID: 0031729801     PISSN: 87560437     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2388(199812)15:4<209::AID-SSU3>3.0.CO;2-D     Document Type: Conference Paper

References (18)

1. Martin EW Jr, Tuttle SE, Rousseau M, et al: Radioimmunoguided surgery: intraoperative use of monoclonal antibody 17-1 A in colorectal cancer. Hybridoma 1986;5 Suppl 1:S97-108.
2. Lee WJ, Lee PH, Yue SC, et al: Lymph node metastases in gastric cancer: significance of positive number. Oncology 1995;52:45-50.
3. Ravichandran D, Lamah M, Carty NJ, Johnson CD: Extended lymph node dissection (D2 resection) should now be performed routinely in the curative surgical treatment of gastric carcinoma [Review]. Ann R Coll Surg Engl 1995;77:431-436.
4. Taat CW, van Laschot JJ, Gouma DJ, Obertop H: Role of extended lymph node dissection in the treatment of gastrointestinal tumours: a review of the literature [Review]. Scand J Gastroenterol Suppl 1995;212:109-116.
5. Takahashi M, Fujimoto S, Kobayashi K, et al: Indication for splenectomy combined with total gastrectomy for gastric cancer analysis of data on 249 gastric cancer patients. Hepatogastroenterology 1995;42:230-233.
6. Japanese Research Society for Gastric Cancer. The general rules for the gastric cancer study in surgery and pathology: pts I and II. Jpn J Surg 1981;11:127-145.
7. Henson DE, Hutter RV, Kennedy BJ (eds): "Manual for staging of cancer." American Joint Committee on Cancer. 4th ed. Philadelphia. Lippincott; 1992. p. 63-67.
8. Crucitti F, Doglietto GB, Bellantone R, et al: Stomach cancer: a study of 117 consecutive resected cases and results of R2-R3 gastrectomy. Int Surg 1991;76.23-26.
9. Kim JP, Hur YS, Yang HK: Lymph node metastasis as a significant prognostic factor in early gastric cancer: analysis of 1,136 early gastric cancers Ann Surg Oncol 1995;2:308-313
10. Shriver CD, Karpeh M, Brennan MF: Extended lymph node dissection in gastric cancer. Surg Oncol Clin N Am 1993;2:393-411.
11. Adachi Y, Mon M, Maehara Y, Sugimachi K: Macroscopically nodenegative but histologically node-positive gastric carcinoma. Br J Surg 1995;82-1254-1256
12. Noguchi Y, Imada T, Matsumoto A, et al: Radical surgery for gastric cancer. A review of the Japanese experience [Review]. Cancer 1989;64:2053-2062.
13. Baba H, Maehara Y, Inutsuka S, et al: Effectiveness of extended lymphadenectomy in noncurative gastrectomy [comment in: Am J Surg 1996;172:303] Am J Surg 1995;169:261-264.
14. Bunt AM, Hogendoorn PC, van de Velde CJ, et al: Lymph node staging standards in gastric cancer. J Clin Oncol 1995;13:2309-2316.
15. Hermanek P, Henson DE, Hutter RP, Sobin LH (eds): "TNM classification of malignant tumours. TNM Supplement 1993: a commentary on uniform use." New York: Springer-Verlag; 1993. p. 49-71.
16. Roder JD, Bonenkamp JJ, Craven J, et al: Lymphadenectomy for gastric cancer in clinical trials: update [Review]. World J Sura 1995;19:546-553.
17. Bonenkamp JJ, Songun I, Hermans J, et al: Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients [comments in: Lancet 1995;345(8952):742-743: Lancet 1995;345(8963):1515-1518]. Lancet 1995:345 (8952)-745-748.
18. Xu G, Zhang M, Liu B. et al: Radioimmunoguided surgery in gastric cancer using 131-1 labeled monoclonal antibody 3H11. Semin Surg Oncol 1994;10:88-94.